Top 10 Anti Rabies Vaccine Manufacturers

April 19, 2024

The global anti-rabies vaccine market is projected to witness significant growth due to increasing awareness about Rabies Prevention, rising pet adoption rates, and government initiatives for mass vaccination programs. Technological advancements in vaccine development are also driving market growth.

GlaxoSmithKline
Serum Institute of India
Beijing Institute of Biological Products
Changchun Zhuoyi Biological Co., Ltd
Chengdu Institute of Biological Products
Pfizer

GlaxoSmithKline

Establishment time : January 1, 2000

website : www.gsk.com

Main Product : Pharmaceuticals, vaccines, consumer healthcare products

Company Profile

GlaxoSmithKline is a leading global healthcare company that researches, develops, and manufactures a wide range of pharmaceuticals, vaccines, and consumer healthcare products. With a strong presence in key markets around the world, GSK is dedicated to improving the quality of human life by providing innovative and effective healthcare solutions.

Serum Institute of India

Establishment time : Serum Institute of India was established in 1966.

website : www.seruminstitute.com

Main Product : Its main products are vaccines.

Company Profile

The company is renowned for its contribution to public health through its wide range of vaccines.

Beijing Institute of Biological Products

Establishment time : 1967

website : http://www.bjbp.com.cn/

Main Product : Vaccines, biological products

Company Profile

Beijing Institute of Biological Products is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. Established in 1967, the company has a strong presence in both the domestic and international markets, offering a wide range of high-quality products to meet the healthcare needs of people worldwide.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Chengdu Institute of Biological Products

Establishment time : 1967

website : www.cibp.com.cn

Main Product : Vaccines, biological products

Company Profile

Chengdu Institute of Biological Products is a renowned biopharmaceutical company established in 1967. With a focus on vaccines and biological products, the company has grown to become a major player in the industry. With a large company size and a strong presence in both domestic and international markets, CIBP is known for its high-quality products and innovative research and development efforts.

Pfizer

Establishment time : Pfizer is a global pharmaceutical company with a long history of innovation and research.

website :

Main Product : Pfizer is committed to improving global health through its products and partnerships.

Company Profile

Overall, Pfizer is a leading player in the pharmaceutical industry, driving advancements in healthcare.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326